Parth Medical

 Molnunat 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults.

Molnumize 200 Capsule is an oral antiviral medicine used to treat mild to moderate COVID-19 (coronavirus disease caused by a virus known as SARS-CoV-2) in adults. It helps in reducing viral load and disease severity by preventing the virus from multiplying.

 ivermectin is known to cause mild side-effects such as diarrhoea, nausea, dizziness and sleepiness. Less common, but serious, side-effects include severe skin rashes and effects on the nervous system (causing tremor, confusion and drowsiness).

Ivermectin is an anti-parasite medication used to treat a variety of parasitic diseases such as parasitic worms, hookworm and whipworm.

Minimum order quantity: 40 Bottle

Movfor Capsule contains molnupiravir an antiviral medicine as its active ingredient. It is used for the treatment of Covid-19 disease in adult patients who have high risk of progression of the disease. The dose, frequency and duration of the treatment are decided by your doctor after accessing your condition. Before initiating treatment with the Movfor Capsule, inform your doctor if you are pregnant, breastfeeding, suffering from any liver or kidney problems or are allergic to it. A person infected with coronavirus should stay in isolation in a well-ventilated space and should follow COVID-19 appropriate behavior to prevent the spread of infection.

Minimum order quantity: 10 Stripe

Artesunate is used in the treatment of malaria. It is not used to prevent malaria or to treat severe malaria (where it has affected the brain, lungs or kidneys). Artesunate is an antiparasitic medication. It works by producing harmful chemicals (free radicals) within the malarial parasite, thereby killing it.

Barilup 4mg Tablet is used in combination with Remdesivir for the treatment of coronavirus disease (COVID-19) in hospitalized adults.

treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (aged a%0Y=12 years and weight a%0Y=40 kg) testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and who are at high risk for progression to severe COVID-19, including hospitalization or death